A Case of Persistent Helicobacter pylori Infection Occurring with Anti-IgE Immunosuppression
| Autor: | Steven F. Moss, William C. Hahn, Daniel Zandman |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
Helicobacter pylori infection
biology business.industry medicine.drug_class medicine.medical_treatment Stomach Immunosuppressive regimen Immunosuppression Case Report General Medicine Omalizumab Helicobacter pylori biology.organism_classification Monoclonal antibody Immunoglobulin E Antimicrobial Immunology biology.protein Medicine business medicine.drug |
| Zdroj: | ACG Case Reports Journal |
| ISSN: | 2326-3253 |
| Popis: | The increasingly widespread use of novel immunosuppressive drugs may lead to unexpected infectious complications. We report a case of persistent Helicobacter pylori (H. pylori) infection that failed to respond to antimicrobial therapy in a patient receiving omalizumab (Xolair™, Genentech USA Inc., San Francisco, CA and Novartis Pharmaceuticals, Basel, Switzerland), an anti-IgE monoclonal antibody approved by the FDA for treatment of severe persistent asthma. To our knowledge, this is the first case report linking an immunosuppressive regimen containing anti-IgE biologic therapy to persistent H. pylori infection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|